Pharmacina Ltd - Accounts to registrar (filleted) - small 18.2

REGISTERED NUMBER: 04445887 (England and Wales)

REPORT OF THE DIRECTOR AND

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MAY 2018

FOR

PHARMACINA LTD

Page

Company Information

1

Report of the Director

2

Balance Sheet

3

Notes to the Financial Statements

4

DIRECTOR:

Dr M Rad-Niknam

REGISTERED OFFICE:

5 Monmouth Place

Bath

BA1 2AT

REGISTERED NUMBER:

04445887 (England and Wales)

ACCOUNTANTS:

JSH Accountancy Limited

584 Wellsway

Bath

Somerset

BA2 2UE

The director presents his report with the financial statements of the company for the year ended 31 May 2018.

DIRECTOR

Dr M Rad-Niknam held office during the whole of the period from 1 June 2017 to the date of this report.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small

companies.

ON BEHALF OF THE BOARD:

Dr M Rad-Niknam - Director

19 February 2019

FIXED ASSETS

Tangible assets

3

168

168

CURRENT ASSETS

Stocks

9,389

9,389

Cash at bank

1,080

1,080

10,469

10,469

CREDITORS

Amounts falling due within one year

4

(49,240

)

(49,061

)

NET CURRENT LIABILITIES

(38,771

)

(38,592

)

TOTAL ASSETS LESS CURRENT LIABILITIES

(38,603

)

(38,424

)

CAPITAL AND RESERVES

Called up share capital

50,000

50,000

Retained earnings

(88,603

)

(88,424

)

SHAREHOLDERS' FUNDS

(38,603

)

(38,424

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2018.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2018 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director on 19 February 2019 and were signed by:

Dr M Rad-Niknam - Director

1.	STATUTORY INFORMATION

Pharmacina Ltd is a private company, limited by shares , registered in England and Wales. The company's

registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment

-

25% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow

moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to

the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or

substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance

sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from

those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that

have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the

timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they

will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	TANGIBLE FIXED ASSETS

Computer

equipment

£

COST

At 1 June 2017

and 31 May 2018

3,138

DEPRECIATION

At 1 June 2017

and 31 May 2018

2,970

NET BOOK VALUE

At 31 May 2018

168

At 31 May 2017

168

4.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2018

2017

£

£

Trade creditors

10,009

10,009

VAT

6

6

Directors' loan accounts

39,046

39,046

Accrued expenses

179

-

49,240

49,061